Nu Skin Enterprises (NYSE:NUS) Releases Q1 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its first quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 0.100-0.200 for the period, compared to the consensus earnings per share estimate of 0.160. The company issued revenue guidance of $345.0 million-$365.0 million, compared to the consensus revenue estimate of $404.6 million. Nu Skin Enterprises also updated its FY 2025 guidance to 0.900-1.300 EPS.

Wall Street Analysts Forecast Growth

Several research analysts have commented on NUS shares. Citigroup cut their price objective on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd. DA Davidson reduced their target price on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating for the company in a research note on Friday, December 20th. Finally, StockNews.com raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Monday, November 11th.

Nu Skin Enterprises Stock Performance

Shares of NYSE NUS opened at $6.41 on Friday. The stock’s fifty day simple moving average is $6.91 and its 200 day simple moving average is $7.50. The stock has a market capitalization of $318.39 million, a price-to-earnings ratio of -3.09 and a beta of 1.17. The company has a quick ratio of 1.20, a current ratio of 1.93 and a debt-to-equity ratio of 0.53. Nu Skin Enterprises has a 52-week low of $5.95 and a 52-week high of $17.68.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a positive return on equity of 5.47% and a negative net margin of 5.81%. As a group, sell-side analysts forecast that Nu Skin Enterprises will post 0.68 earnings per share for the current fiscal year.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.